{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:26:02Z","timestamp":1769243162436,"version":"3.49.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00105-017-4018-0","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T13:37:05Z","timestamp":1502890625000},"page":"727-739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aggressive prim\u00e4r kutane B-Zell\ufeff-Lymphome und neue EBV-positive Entit\u00e4ten","Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities"],"prefix":"10.1007","volume":"68","author":[{"given":"C.","family":"Lamos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"4018_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et\u00a0al (2016) The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood 127:2375. doi: 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"4018_CR2","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","volume":"105","author":"JJ Hoefnagel","year":"2005","unstructured":"Hoefnagel JJ, Dijkman R, Basso K et al (2005) Distinct types of primary cutaneous large B\u2011cell lymphoma identified by gene expression profiling. Blood 105:3671\u20133678","journal-title":"Blood"},{"key":"4018_CR3","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.1998.16.6.2080","volume":"16","author":"FA Geelen","year":"1998","unstructured":"Geelen FA, Vermeer MH, Meijer CJ et al (1998) bcl-2 protein expression in primary cutaneous large B\u2011cell lymphoma is site-related. J\u00a0Clin Oncol 16:2080\u20132085","journal-title":"J Clin Oncol"},{"key":"4018_CR4","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","volume":"19","author":"F Grange","year":"2001","unstructured":"Grange F, Bekkenk MW, Wechsler J et al (2001) Prognostic factors in primary cutaneous large B\u2011cell lymphomas: a\u00a0European multicenter study. J\u00a0Clin Oncol 19:3602\u20133610","journal-title":"J Clin Oncol"},{"key":"4018_CR5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.0022-202X.2003.12635.x","volume":"122","author":"C Hallermann","year":"2004","unstructured":"Hallermann C, Kaune KM, Siebert R et\u00a0al (2004) Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. J\u00a0Invest Dermatol 122:1495\u20131502","journal-title":"J Invest Dermatol"},{"key":"4018_CR6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.10104","volume":"35","author":"X Mao","year":"2002","unstructured":"Mao X, Lillington D, Child F et al (2002) Comparative genomic hybridization analysis of primary cutaneous B\u2011cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35:144\u2013155","journal-title":"Genes Chromosomes Cancer"},{"key":"4018_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","volume":"123","author":"C Hallermann","year":"2004","unstructured":"Hallermann C, Kaune KM, Gesk S et al (2004) Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B\u2011cell lymphomas. J\u00a0Invest Dermatol 123:213\u2013219","journal-title":"J Invest Dermatol"},{"key":"4018_CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","volume":"27","author":"A Pham-Ledard","year":"2014","unstructured":"Pham-Ledard A, Prochazkova-Carlotti M, Andrique L et al (2014) Multiple genetic alterations in primary cutaneous large B\u2011cell lymphoma, leg type support a\u00a0common lymphomagenesis with activated B\u2011cell-like diffuse large B\u2011cell lymphoma. Mod Pathol 27:402\u2013411","journal-title":"Mod Pathol"},{"key":"4018_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jid.2013.265","volume":"134","author":"L Koens","year":"2014","unstructured":"Koens L, Zoutman WH, Ngarmlertsirichai P et al (2014) Nuclear factor-kappaB pathway-activating gene aberrancies in primary cutaneous large B\u2011cell lymphoma, leg type. J\u00a0Invest Dermatol 134:290\u2013292","journal-title":"J Invest Dermatol"},{"key":"4018_CR10","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE Davis","year":"2001","unstructured":"Davis RE, Brown KD, Siebenlist U, Staudt LM (2001) Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J\u00a0Exp Med 194:1861\u20131874","journal-title":"J Exp Med"},{"key":"4018_CR11","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","volume":"132","author":"A Pham-Ledard","year":"2012","unstructured":"Pham-Ledard A, Cappellen D, Martinez F et al (2012) MYD88 somatic mutation is a\u00a0genetic feature of primary cutaneous diffuse large B\u2011cell lymphoma, leg type. J\u00a0Invest Dermatol 132:2118\u20132120","journal-title":"J Invest Dermatol"},{"key":"4018_CR12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","volume":"150","author":"A Pham-Ledard","year":"2014","unstructured":"Pham-Ledard A, Beylot-Barry M, Barbe C et al (2014) High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B\u2011cell lymphoma, leg-type. JAMA Dermatol 150:1173\u20131179","journal-title":"JAMA Dermatol"},{"key":"4018_CR13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"YH Kim","year":"2007","unstructured":"Kim YH, Willemze R, Pimpinelli N et\u00a0al (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a\u00a0proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:479\u2013484","journal-title":"Blood"},{"key":"4018_CR14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","volume":"25","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Jansen PM et al (2007) Reclassification of 300 primary cutaneous B\u2011Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J\u00a0Clin Oncol 25:1581\u20131587","journal-title":"J Clin Oncol"},{"key":"4018_CR15","doi-asserted-by":"crossref","first-page":"329 e1","DOI":"10.1016\/j.jaad.2013.06.012","volume":"69","author":"AL Suarez","year":"2013","unstructured":"Suarez AL, Pulitzer M, Horwitz S et al (2013) Primary cutaneous B\u2011cell lymphomas: part I. Clinical features, diagnosis, and classification. J\u00a0Am Acad Dermatol 69:329 e1\u2013329 e13 (quiz 41\u20132)","journal-title":"J Am Acad Dermatol"},{"key":"4018_CR16","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","volume":"112","author":"NJNE Senff","year":"2008","unstructured":"Senff NJNE, Kim YH, Bagot M, Berti E, Cerroni L et al (2008) European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B\u2011cell lymphomas. Blood 112:1600\u20131609","journal-title":"Blood"},{"key":"4018_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.leu.2404479","volume":"21","author":"PA Evans","year":"2007","unstructured":"Evans PA, Pott C, Groenen PJ et al (2007) Significantly improved PCR-based clonality testing in B\u2011cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:207\u2013214","journal-title":"Leukemia"},{"key":"4018_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2404467","volume":"21","author":"JH Krieken van","year":"2007","unstructured":"van Krieken JH, Langerak AW, Macintyre EA et al (2007) Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:201\u2013206","journal-title":"Leukemia"},{"key":"4018_CR19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/10428190500305380","volume":"47","author":"A Lukowsky","year":"2006","unstructured":"Lukowsky A, Marchwat M, Sterry W, Gellrich S (2006) Evaluation of B\u2011cell clonality in archival skin biopsy samples of cutaneous B\u2011cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction. Leuk Lymphoma 47:487\u2013493","journal-title":"Leuk Lymphoma"},{"key":"4018_CR20","first-page":"659","volume":"88","author":"Y Sandberg","year":"2003","unstructured":"Sandberg Y, Heule F, Lam K et al (2003) Molecular immunoglobulin\/T-cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol. Haematologica 88:659\u2013670","journal-title":"Haematologica"},{"key":"4018_CR21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","volume":"55","author":"HT Eich","year":"2003","unstructured":"Eich HT, Eich D, Micke O et al (2003) Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B\u2011cell lymphoma. Int J Radiat Oncol Biol Phys 55:899\u2013906","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4018_CR22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2000.03471.x","volume":"142","author":"K Gronbaek","year":"2000","unstructured":"Gronbaek K, Moller PH, Nedergaard T et al (2000) Primary cutaneous B\u2011cell lymphoma: a\u00a0clinical, histological, phenotypic and genotypic study of 21 cases. Br J Dermatol 142:913\u2013923","journal-title":"Br J Dermatol"},{"key":"4018_CR23","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","volume":"143","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Neelis KJ et al (2007) Results of radiotherapy in 153 primary cutaneous B\u2011Cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143:1520\u20131526","journal-title":"Arch Dermatol"},{"key":"4018_CR24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","volume":"22","author":"BD Smith","year":"2004","unstructured":"Smith BD, Glusac EJ, McNiff JM et al (2004) Primary cutaneous B\u2011cell lymphoma treated with radiotherapy: a\u00a0comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J\u00a0Clin Oncol 22:634\u2013639","journal-title":"J Clin Oncol"},{"key":"4018_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s001050050005","volume":"51","author":"P Zenahlik","year":"2000","unstructured":"Zenahlik P, Fink-Puches R, Kapp KS et al (2000) Therapy of primary cutaneous B\u2011cell lymphomas. Hautarzt 51:19\u201324","journal-title":"Hautarzt"},{"key":"4018_CR26","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","volume":"27","author":"JR Goodlad","year":"2003","unstructured":"Goodlad JR, Krajewski AS, Batstone PJ et al (2003) Primary cutaneous diffuse large B\u2011cell lymphoma: prognostic significance of clinicopathological subtypes. Am J Surg Pathol 27:1538\u20131545","journal-title":"Am J Surg Pathol"},{"key":"4018_CR27","first-page":"49","volume":"13","author":"R Piccinno","year":"2003","unstructured":"Piccinno R, Caccialanza M, Berti E (2003) Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma. Eur J Dermatol 13:49\u201352","journal-title":"Eur J Dermatol"},{"key":"4018_CR28","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","volume":"24","author":"PL Zinzani","year":"2006","unstructured":"Zinzani PL, Quaglino P, Pimpinelli N et al (2006) Prognostic factors in primary cutaneous B\u2011cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J\u00a0Clin Oncol 24:1376\u20131382","journal-title":"J Clin Oncol"},{"key":"4018_CR29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/hupa.2002.126881","volume":"33","author":"M Paulli","year":"2002","unstructured":"Paulli M, Viglio A, Vivenza D et al (2002) Primary cutaneous large B\u2011cell lymphoma of the leg: histogenetic analysis of a\u00a0controversial clinicopathologic entity. Hum Pathol 33:937\u2013943","journal-title":"Hum Pathol"},{"key":"4018_CR30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","volume":"150","author":"F Grange","year":"2014","unstructured":"Grange F, Joly P, Barbe C et al (2014) Improvement of survival in patients with primary cutaneous diffuse large B\u2011cell lymphoma, leg type, in France. JAMA Dermatol 150:535\u2013541","journal-title":"JAMA Dermatol"},{"key":"4018_CR31","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/annonc\/mdq671","volume":"22","author":"E Weidmann","year":"2011","unstructured":"Weidmann E, Neumann A, Fauth F et al (2011) Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B\u2011cell lymphomas. Ann Oncol 22:1839\u20131844","journal-title":"Ann Oncol"},{"key":"4018_CR32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjh.14232","volume":"175","author":"SI Park","year":"2016","unstructured":"Park SI, Grover NS, Olajide O et al (2016) A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B\u2011cell lymphoma. Br J Haematol 175:281\u2013289","journal-title":"Br J Haematol"},{"key":"4018_CR33","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1200\/JCO.2012.46.5203","volume":"31","author":"K Ohmachi","year":"2013","unstructured":"Ohmachi K, Niitsu N, Uchida T et al (2013) Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B\u2011cell lymphoma. J\u00a0Clin Oncol 31:2103\u20132109","journal-title":"J Clin Oncol"},{"key":"4018_CR34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00105-013-2736-5","volume":"65","author":"JP Nicolay","year":"2014","unstructured":"Nicolay JP, Klemke CD (2014) Management of cutaneous lymphomas. Hautarzt 65:607\u2013613","journal-title":"Hautarzt"},{"key":"4018_CR35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ejh.12315","volume":"93","author":"A Fabbri","year":"2014","unstructured":"Fabbri A, Cencini E, Alterini R et al (2014) Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B\u2011cell lymphomas. Eur J Haematol 93:129\u2013136","journal-title":"Eur J Haematol"},{"key":"4018_CR36","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1158\/0008-5472.CAN-10-2525","volume":"71","author":"TL Naylor","year":"2011","unstructured":"Naylor TL, Tang H, Ratsch BA et al (2011) Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B\u2011cell lymphomas. Cancer Res 71:2643\u20132653","journal-title":"Cancer Res"},{"issue":"21","key":"4018_CR37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood.V120.21.686.686","volume":"120","author":"WHGJ Wilson","year":"2012","unstructured":"Wilson WHGJ, Goy A (2012) The Bruton\u2019s tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), has preferential activity in the ABC subtype of relapsed\/refractory de novo diffuse large B\u2011cell lymphoma (DLBCL): interim results of a\u00a0multicenter, open-label, phase 2 study. Blood 120(21):686","journal-title":"Blood"},{"key":"4018_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.23863","volume":"90","author":"RA Wilcox","year":"2015","unstructured":"Wilcox RA (2015) Cutaneous B\u2011cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Am J Hematol 90:73\u201376","journal-title":"Am J Hematol"},{"key":"4018_CR39","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","volume":"117","author":"SD Dojcinov","year":"2011","unstructured":"Dojcinov SD, Venkataraman G, Pittaluga S et al (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a\u00a0spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726\u20134735","journal-title":"Blood"},{"key":"4018_CR40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","volume":"126","author":"A Nicolae","year":"2015","unstructured":"Nicolae A, Pittaluga S, Abdullah S et al (2015) EBV-positive large B\u2011cell lymphomas in young patients: a\u00a0nodal lymphoma with evidence for a\u00a0tolerogenic immune environment. Blood 126:863\u2013872","journal-title":"Blood"},{"key":"4018_CR41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2015-06-648097","volume":"126","author":"J Said","year":"2015","unstructured":"Said J (2015) The expanding spectrum of EBV+ lymphomas. Blood 126:827\u2013828","journal-title":"Blood"},{"key":"4018_CR42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semdp.2016.11.003","volume":"34","author":"AA Gru","year":"2017","unstructured":"Gru AA, Jaffe ES (2017) Cutaneous EBV-related lymphoproliferative disorders. Semin Diagn Pathol 34:60\u201375","journal-title":"Semin Diagn Pathol"},{"key":"4018_CR43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri2318","volume":"8","author":"J Nikolich-Zugich","year":"2008","unstructured":"Nikolich-Zugich J (2008) Ageing and life-long maintenance of T\u2011cell subsets in the face of latent persistent infections. Nat Rev Immunol 8:512\u2013522","journal-title":"Nat Rev Immunol"},{"key":"4018_CR44","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","volume":"174","author":"K Naylor","year":"2005","unstructured":"Naylor K, Li G, Vallejo AN et\u00a0al (2005) The influence of age on T cell generation and TCR diversity. J\u00a0Immunol 174:7446\u20137452","journal-title":"J Immunol"},{"key":"4018_CR45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","volume":"120","author":"D Aw","year":"2007","unstructured":"Aw D, Silva AB, Palmer DB (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120:435\u2013446","journal-title":"Immunology"},{"key":"4018_CR46","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2012.52","volume":"25","author":"S Montes-Moreno","year":"2012","unstructured":"Montes-Moreno S, Odqvist L, Diaz-Perez JA et al (2012) EBV-positive diffuse large B\u2011cell lymphoma of the elderly is an aggressive post-germinal center B\u2011cell neoplasm characterized by prominent nuclear factor-kB activation. Mod Pathol 25:968\u2013982","journal-title":"Mod Pathol"},{"key":"4018_CR47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/cas.12389","volume":"105","author":"H Kato","year":"2014","unstructured":"Kato H, Karube K, Yamamoto K et al (2014) Gene expression profiling of Epstein-Barr virus-positive diffuse large B\u2011cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways. Cancer Sci 105:537\u2013544","journal-title":"Cancer Sci"},{"key":"4018_CR48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757\u2013768","journal-title":"Nat Rev Cancer"},{"key":"4018_CR49","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","volume":"3","author":"R Kuppers","year":"2003","unstructured":"Kuppers R (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801\u2013812","journal-title":"Nat Rev Immunol"},{"key":"4018_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252\u2013264","journal-title":"Nat Rev Cancer"},{"key":"4018_CR51","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","volume":"17","author":"J Godin-Ethier","year":"2011","unstructured":"Godin-Ethier J, Hanafi LA, Piccirillo CA, Lapointe R (2011) Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clin Cancer Res 17:6985\u20136991","journal-title":"Clin Cancer Res"},{"key":"4018_CR52","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","volume":"13","author":"T Oyama","year":"2007","unstructured":"Oyama T, Yamamoto K, Asano N et al (2007) Age-related EBV-associated B\u2011cell lymphoproliferative disorders constitute a\u00a0distinct clinicopathologic group: a\u00a0study of 96 patients. Clin Cancer Res 13:5124\u20135132","journal-title":"Clin Cancer Res"},{"key":"4018_CR53","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","volume":"113","author":"N Asano","year":"2009","unstructured":"Asano N, Yamamoto K, Tamaru J et al (2009) Age-related Epstein-Barr virus (EBV)-associated B\u2011cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 113:2629\u20132636","journal-title":"Blood"},{"key":"4018_CR54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","volume":"99","author":"Y Shimoyama","year":"2008","unstructured":"Shimoyama Y, Yamamoto K, Asano N et al (2008) Age-related Epstein-Barr virus-associated B\u2011cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 99:1085\u20131091","journal-title":"Cancer Sci"},{"key":"4018_CR55","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1440-1827.2009.02466.x","volume":"59","author":"Y Shimoyama","year":"2009","unstructured":"Shimoyama Y, Asano N, Kojima M et al (2009) Age-related EBV-associated B\u2011cell lymphoproliferative disorders: diagnostic approach to a\u00a0newly recognized clinicopathological entity. Pathol Int 59:835\u2013843","journal-title":"Pathol Int"},{"key":"4018_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","volume":"46","author":"Y Shimoyama","year":"2006","unstructured":"Shimoyama Y, Oyama T, Asano N et al (2006) Senile Epstein-Barr virus-associated B\u2011cell lymphoproliferative disorders: a\u00a0mini review. J\u00a0Clin Exp Hematop 46:1\u20134","journal-title":"J Clin Exp Hematop"},{"key":"4018_CR57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ced.12322","volume":"39","author":"B Unamuno Bustos De","year":"2014","unstructured":"De Unamuno Bustos B, Zaragoza Ninet V, Ballester Sanchez R et al (2014) Epstein-Barr virus-positive diffuse large B\u2011cell lymphoma in an elderly patient. Clin Exp Dermatol 39:484\u2013487","journal-title":"Clin Exp Dermatol"},{"key":"4018_CR58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","volume":"122","author":"CY Ok","year":"2013","unstructured":"Ok CY, Papathomas TG, Medeiros LJ, Young KH (2013) EBV-positive diffuse large B\u2011cell lymphoma of the elderly. Blood 122:328\u2013340","journal-title":"Blood"},{"key":"4018_CR59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajh.24370","volume":"91","author":"JJ Castillo","year":"2016","unstructured":"Castillo JJ, Beltran BE, Miranda RN et al (2016) EBV-positive diffuse large B\u2011cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91:529\u2013537","journal-title":"Am J Hematol"},{"key":"4018_CR60","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","volume":"23","author":"P Feugier","year":"2005","unstructured":"Feugier P, Van Hoof A, Sebban C et al (2005) Long-term results of the R\u2011CHOP study in the treatment of elderly patients with diffuse large B\u2011cell lymphoma: a\u00a0study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J\u00a0Clin Oncol 23:4117\u20134126","journal-title":"J Clin Oncol"},{"key":"4018_CR61","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","volume":"110","author":"S Park","year":"2007","unstructured":"Park S, Lee J, Ko YH et al (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B\u2011cell lymphoma. Blood 110:972\u2013978","journal-title":"Blood"},{"key":"4018_CR62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.22078","volume":"86","author":"BE Beltran","year":"2011","unstructured":"Beltran BE, Castillo JJ, Morales D et al (2011) EBV-positive diffuse large B\u2011cell lymphoma of the elderly: a\u00a0case series from Peru. Am J Hematol 86:663\u2013667","journal-title":"Am J Hematol"},{"key":"4018_CR63","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ajh.23507","volume":"88","author":"JS Ahn","year":"2013","unstructured":"Ahn JS, Yang DH, Duk CY et al (2013) Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B\u2011cell lymphoma treated with a\u00a0combination of rituximab and CHOP chemotherapy. Am J Hematol 88:774\u2013779","journal-title":"Am J Hematol"},{"key":"4018_CR64","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/1078-0432.CCR-13-3157","volume":"20","author":"CY Ok","year":"2014","unstructured":"Ok CY, Li L, Xu-Monette ZY et al (2014) Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B\u2011cell lymphoma in Western countries. Clin Cancer Res 20:2338\u20132349","journal-title":"Clin Cancer Res"},{"key":"4018_CR65","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/cas.12467","volume":"105","author":"A Sato","year":"2014","unstructured":"Sato A, Nakamura N, Kojima M et al (2014) Clinical outcome of Epstein-Barr virus-positive diffuse large B\u2011cell lymphoma of the elderly in the rituximab era. Cancer Sci 105:1170\u20131175","journal-title":"Cancer Sci"},{"key":"4018_CR66","doi-asserted-by":"crossref","first-page":"12168","DOI":"10.1038\/srep12168","volume":"5","author":"TX Lu","year":"2015","unstructured":"Lu TX, Liang JH, Miao Y et al (2015) Epstein-Barr virus positive diffuse large B\u2011cell lymphoma predict poor outcome, regardless of the age. Sci Rep 5:12168","journal-title":"Sci Rep"},{"key":"4018_CR67","doi-asserted-by":"crossref","first-page":"509296","DOI":"10.1155\/2012\/509296","volume":"2012","author":"SK Ghosh","year":"2012","unstructured":"Ghosh SK, Perrine SP, Faller DV (2012) Advances in virus-directed therapeutics against Epstein-Barr virus-associated malignancies. Adv Virol 2012:509296","journal-title":"Adv Virol"},{"key":"4018_CR68","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","volume":"330","author":"EB Papadopoulos","year":"1994","unstructured":"Papadopoulos EB, Ladanyi M, Emanuel D et al (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N\u00a0Engl J Med 330:1185\u20131191","journal-title":"N Engl J Med"},{"key":"4018_CR69","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7555\/JBR.28.20140066","volume":"28","author":"X Tang","year":"2014","unstructured":"Tang X, Zhou Y, Li W et al (2014) T cells expressing a\u00a0LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo. J\u00a0Biomed Res 28:468\u2013475","journal-title":"J Biomed Res"},{"key":"4018_CR70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/10428190903308015","volume":"51","author":"D Morales","year":"2010","unstructured":"Morales D, Beltran B, De Mendoza FH et al (2010) Epstein-Barr virus as a\u00a0prognostic factor in de novo nodal diffuse large B\u2011cell lymphoma. Leuk Lymphoma 51:66\u201372","journal-title":"Leuk Lymphoma"},{"key":"4018_CR71","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"RJE Willemze","year":"2005","unstructured":"Willemze RJE, Burg G, Cerroni L, Berti E, Swerdlow SH et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u20133785","journal-title":"Blood"},{"key":"4018_CR72","first-page":"762","volume":"111","author":"M Chen","year":"1998","unstructured":"Chen M, Qiu B, Kong J, Chen J (1998) Angiotropic T cell lymphoma. Chin Med J (Engl) 111:762\u2013764","journal-title":"Chin Med J (Engl)"},{"key":"4018_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.2008.01089.x","volume":"81","author":"N Nakamichi","year":"2008","unstructured":"Nakamichi N, Fukuhara S, Aozasa K, Morii E (2008) NK-cell intravascular lymphomatosis \u2013 a mini-review. Eur J Haematol 81:1\u20137","journal-title":"Eur J Haematol"},{"key":"4018_CR74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","volume":"127","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Campo E, Seymour JF et\u00a0al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a\u00a0series of 38 cases, with special emphasis on the \u201ecutaneous variant\u201c. Br J Haematol 127:173\u2013183","journal-title":"Br J Haematol"},{"key":"4018_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1287363","volume":"58","author":"DJ Rajyaguru","year":"2017","unstructured":"Rajyaguru DJ, Bhaskar C, Borgert AJ et al (2017) Intravascular large B\u2011cell lymphoma in the United States (US): a\u00a0population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database. Leuk Lymphoma 58:1\u20139. doi: 10.1080\/10428194.2017.1287363","journal-title":"Leuk Lymphoma"},{"key":"4018_CR76","first-page":"12","volume":"10","author":"W Kempf","year":"2012","unstructured":"Kempf W, Denisjuk N, Kerl K et al (2012) Primary cutaneous B\u2011cell lymphomas. J\u00a0Dtsch Dermatol Ges 10:12\u201322 (quiz 23)","journal-title":"J Dtsch Dermatol Ges"},{"key":"4018_CR77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","volume":"36","author":"W Kempf","year":"2014","unstructured":"Kempf W, Kazakov DV, Mitteldorf C (2014) Cutaneous lymphomas: an update. Part 2: B\u2011cell lymphomas and related conditions. Am J Dermatopathol 36:197\u2013208 (quiz 09\u201310)","journal-title":"Am J Dermatopathol"},{"key":"4018_CR78","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","volume":"25","author":"M Ponzoni","year":"2007","unstructured":"Ponzoni M, Ferreri AJ, Campo E et al (2007) Definition, diagnosis, and management of intravascular large B\u2011cell lymphoma: proposals and perspectives from an international consensus meeting. J\u00a0Clin Oncol 25:3168\u20133173","journal-title":"J Clin Oncol"},{"key":"4018_CR79","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000478-199707000-00016","volume":"21","author":"MA Rubin","year":"1997","unstructured":"Rubin MA, Cossman J, Freter CE, Azumi N (1997) Intravascular large cell lymphoma coexisting within hemangiomas of the skin. Am J Surg Pathol 21:860\u2013864","journal-title":"Am J Surg Pathol"},{"key":"4018_CR80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2133.2000.03608.x","volume":"143","author":"T Kobayashi","year":"2000","unstructured":"Kobayashi T, Munakata S, Sugiura H et\u00a0al (2000) Angiotropic lymphoma: proliferation of B cells in the capillaries of cutaneous angiomas. Br J Dermatol 143:162\u2013164","journal-title":"Br J Dermatol"},{"key":"4018_CR81","doi-asserted-by":"crossref","first-page":"e5985","DOI":"10.1097\/MD.0000000000005985","volume":"96","author":"V Brunet","year":"2017","unstructured":"Brunet V, Marouan S, Routy JP et al (2017) Retrospective study of intravascular large B\u2011cell lymphoma cases diagnosed in Quebec: a retrospective study of 29 case reports. Medicine (Baltimore) 96:e5985","journal-title":"Medicine (Baltimore)"},{"key":"4018_CR82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hon.2900070303","volume":"7","author":"P Domizio","year":"1989","unstructured":"Domizio P, Hall PA, Cotter F et\u00a0al (1989) Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol 7:195\u2013206","journal-title":"Hematol Oncol"},{"key":"4018_CR83","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/ddg.12953","volume":"14","author":"S Hurlbeck","year":"2016","unstructured":"Hurlbeck S, Weidenthaler-Barth B, Butsch F (2016) Early diagnosis of intravascular large B\u2011cell lymphoma. J\u00a0Dtsch Dermatol Ges 14:1146\u20131148","journal-title":"J Dtsch Dermatol Ges"},{"key":"4018_CR84","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1200\/JCO.1994.12.12.2573","volume":"12","author":"JA DiGiuseppe","year":"1994","unstructured":"DiGiuseppe JA, Nelson WG, Seifter EJ et\u00a0al (1994) Intravascular lymphomatosis: a\u00a0clinicopathologic study of 10 cases and assessment of response to chemotherapy. J\u00a0Clin Oncol 12:2573\u20132579","journal-title":"J Clin Oncol"},{"key":"4018_CR85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archneur.57.3.374","volume":"57","author":"TP Baumann","year":"2000","unstructured":"Baumann TP, Hurwitz N, Karamitopolou-Diamantis E et al (2000) Diagnosis and treatment of intravascular lymphomatosis. Arch Neurol 57:374\u2013377","journal-title":"Arch Neurol"},{"key":"4018_CR86","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/1097-0142(20001215)89:12<2515::AID-CNCR1>3.0.CO;2-H","volume":"89","author":"DM Savarese","year":"2000","unstructured":"Savarese DM, Zavarin M, Smyczynski MS et\u00a0al (2000) Superior vena cava syndrome secondary to an angiotropic large cell lymphoma. Cancer 89:2515\u20132520","journal-title":"Cancer"},{"key":"4018_CR87","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.bmt.1703038","volume":"27","author":"M Koizumi","year":"2001","unstructured":"Koizumi M, Nishimura M, Yokota A et al (2001) Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 27:1101\u20131103","journal-title":"Bone Marrow Transplant"},{"key":"4018_CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bmt.1702735","volume":"27","author":"M Yamaguchi","year":"2001","unstructured":"Yamaguchi M, Kimura M, Watanabe Y et\u00a0al (2001) Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis. Bone Marrow Transplant 27:89\u201391","journal-title":"Bone Marrow Transplant"},{"key":"4018_CR89","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2141.1999.1368a.x","volume":"105","author":"C Rose","year":"1999","unstructured":"Rose C, Staumont D, Jouet JP (1999) Successful autologous bone marrow transplantation in intravascular lymphomatosis. Br J Haematol 105:313\u2013314","journal-title":"Br J Haematol"},{"key":"4018_CR90","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.2008.07338.x","volume":"143","author":"AJ Ferreri","year":"2008","unstructured":"Ferreri AJ, Dognini GP, Bairey O et al (2008) The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in \u201aWestern\u2018 patients with intravascular large B\u2011cell lymphoma. Br J Haematol 143:253\u2013257","journal-title":"Br J Haematol"},{"key":"4018_CR91","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2008.12.045","volume":"61","author":"B Horvath","year":"2009","unstructured":"Horvath B, Demeter J, Eros N et al (2009) Intravascular large B\u2011cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy. J\u00a0Am Acad Dermatol 61:885\u2013888","journal-title":"J Am Acad Dermatol"},{"key":"4018_CR92","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000228328","volume":"219","author":"R Feldmann","year":"2009","unstructured":"Feldmann R, Schierl M, Sittenthaler M et al (2009) Intravascular large B\u2011cell lymphoma of the skin: typical clinical manifestations and a\u00a0favourable response to rituximab-containing therapy. Dermatology 219:344\u2013346","journal-title":"Dermatology"},{"key":"4018_CR93","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","volume":"34","author":"SD Dojcinov","year":"2010","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M et\u00a0al (2010) EBV positive mucocutaneous ulcer \u2013 a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405\u2013417","journal-title":"Am J Surg Pathol"},{"key":"4018_CR94","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","volume":"38","author":"M Hart","year":"2014","unstructured":"Hart M, Thakral B, Yohe S et al (2014) EBV-positive mucocutaneous ulcer in organ transplant recipients: a\u00a0localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol 38:1522\u20131529","journal-title":"Am J Surg Pathol"},{"key":"4018_CR95","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/517260","volume":"176","author":"H Kanegane","year":"1997","unstructured":"Kanegane H, Wakiguchi H, Kanegane C et al (1997) Viral interleukin-10 in chronic active Epstein-Barr virus infection. J\u00a0Infect Dis 176:254\u2013257","journal-title":"J Infect Dis"},{"key":"4018_CR96","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.prp.2007.05.002","volume":"203","author":"M Kojima","year":"2007","unstructured":"Kojima M, Kashimura M, Itoh H et al (2007) Epstein-Barr virus-related reactive lymphoproliferative disorders in middle-aged or elderly patients presenting with atypical features. A clinicopathological study of six cases. Pathol Res Pract 203:587\u2013591","journal-title":"Pathol Res Pract"},{"key":"4018_CR97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375\u2013404","journal-title":"Annu Rev Pathol"},{"key":"4018_CR98","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","volume":"38","author":"SA Rezk","year":"2007","unstructured":"Rezk SA, Weiss LM (2007) Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 38:1293\u20131304","journal-title":"Hum Pathol"},{"key":"4018_CR99","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.transproceed.2008.10.085","volume":"41","author":"C Chen","year":"2009","unstructured":"Chen C, Johnston TD, Jeon H et al (2009) Cyclosporine promotes epstein-barr virus-infected human B\u2011cell transformation assayed by three correlated assay methods. Transplant Proc 41:366\u2013370","journal-title":"Transplant Proc"},{"key":"4018_CR100","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1006\/clin.1996.0140","volume":"80","author":"S Ho","year":"1996","unstructured":"Ho S, Clipstone N, Timmermann L et\u00a0al (1996) The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40\u2013S45","journal-title":"Clin Immunol Immunopathol"},{"key":"4018_CR101","first-page":"200","volume":"12","author":"DM Knowles","year":"1999","unstructured":"Knowles DM (1999) Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 12:200\u2013217","journal-title":"Mod Pathol"},{"key":"4018_CR102","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4049\/jimmunol.144.6.2109","volume":"144","author":"GM Pereira","year":"1990","unstructured":"Pereira GM, Miller JF, Shevach EM (1990) Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A\u2011resistant pathway. J\u00a0Immunol 144:2109\u20132116","journal-title":"J Immunol"},{"key":"4018_CR103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1399-3062.2001.003002060.x","volume":"3","author":"JE Tanner","year":"2001","unstructured":"Tanner JE, Alfieri C (2001) The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 3:60\u201369","journal-title":"Transpl Infect Dis"},{"key":"4018_CR104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","volume":"27","author":"T Oyama","year":"2003","unstructured":"Oyama T, Ichimura K, Suzuki R et al (2003) Senile EBV+ B\u2011cell lymphoproliferative disorders: a\u00a0clinicopathologic study of 22 patients. Am J Surg Pathol 27:16\u201326","journal-title":"Am J Surg Pathol"},{"key":"4018_CR105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-0039.2007.00891.x","volume":"70","author":"FT Hakim","year":"2007","unstructured":"Hakim FT, Gress RE (2007) Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens 70:179\u2013189","journal-title":"Tissue Antigens"},{"key":"4018_CR106","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4049\/jimmunol.176.1.301","volume":"176","author":"I Messaoudi","year":"2006","unstructured":"Messaoudi I, Warner J, Nikolich-Zugich D et al (2006) Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo. J\u00a0Immunol 176:301\u2013308","journal-title":"J Immunol"},{"key":"4018_CR107","first-page":"34","volume":"43","author":"G Pawelec","year":"2008","unstructured":"Pawelec G, Larbi A (2008) Immunity and ageing in man: Annual Review 2006\/2007. Exp Gerontol 43:34\u201338","journal-title":"Exp Gerontol"},{"key":"4018_CR108","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0047-6374(03)00026-5","volume":"124","author":"Q Ouyang","year":"2003","unstructured":"Ouyang Q, Wagner WM, Walter S et al (2003) An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a\u00a0decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 124:477\u2013485","journal-title":"Mech Ageing Dev"},{"key":"4018_CR109","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2141.2007.06867.x","volume":"139","author":"P Ghia","year":"2007","unstructured":"Ghia P, Prato G, Stella S et al (2007) Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly. Br J Haematol 139:780\u2013790","journal-title":"Br J Haematol"},{"key":"4018_CR110","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.V98.8.2588","volume":"98","author":"M Bharadwaj","year":"2001","unstructured":"Bharadwaj M, Burrows SR, Burrows JM et al (2001) Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection. Blood 98:2588\u20132589","journal-title":"Blood"},{"key":"4018_CR111","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","volume":"16","author":"LL Laichalk","year":"2002","unstructured":"Laichalk LL, Hochberg D, Babcock GJ et\u00a0al (2002) The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16:745\u2013754","journal-title":"Immunity"},{"key":"4018_CR112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-016-0042-5","volume":"5","author":"TK Roberts","year":"2015","unstructured":"Roberts TK, Chen X, Liao JJ (2015) Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a\u00a0case report and systematic review of the literature. Exp Hematol Oncol 5:13","journal-title":"Exp Hematol Oncol"},{"key":"4018_CR113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.2910350107","volume":"35","author":"QY Yao","year":"1985","unstructured":"Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35:35\u201342","journal-title":"Int J Cancer"},{"key":"4018_CR114","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1126\/science.276.5321.2030","volume":"276","author":"A Moghaddam","year":"1997","unstructured":"Moghaddam A, Rosenzweig M, Lee-Parritz D et al (1997) An animal model for acute and persistent Epstein-Barr virus infection. Science 276:2030\u20132033","journal-title":"Science"},{"key":"4018_CR115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0046-8177(97)90040-X","volume":"28","author":"R Chetty","year":"1997","unstructured":"Chetty R, Biddolph S, Gatter K (1997) An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin\u2019s disease and Reed-Sternberg-like cells in non-Hodgkin\u2019s lymphomas and reactive conditions. Hum Pathol 28:493\u2013498","journal-title":"Hum Pathol"},{"key":"4018_CR116","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2015.245","volume":"51","author":"AA Nelson","year":"2016","unstructured":"Nelson AA, Harrington AM, Kroft S et al (2016) Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer. Bone Marrow Transplant 51:300\u2013302","journal-title":"Bone Marrow Transplant"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4018-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T03:00:39Z","timestamp":1692932439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4018-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":116,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4018"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4018-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]}}}